Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer

Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes

(2013) George Pentheroudakis et al.   BMC CANCER

Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases

(2012) Hidekazu Kuramochi et al.   BMC CANCER

A novel predictive strategy by immunohistochemical analysis of four EGFR ligands in metastatic colorectal cancer treated with anti-EGFR antibodies

(2012) Michihiro Yoshida et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer

(2011) J B Baker et al.   BRITISH JOURNAL OF CANCER

Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab

(2010) Wendy De Roock et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Amphiregulin and Epiregulin Expression in Colorectal Carcinoma and the Correlation with Clinicopathological Characteristics

(2010) Xiao-Dong Li et al.   ONKOLOGIE

Health-Related Quality of Life in Patients With Advanced Colorectal Cancer Treated With Cetuximab: Overall andKRAS-Specific Results of the NCIC CTG and AGITG CO.17 Trial

(2009) Heather-Jane Au et al.   JOURNAL OF CLINICAL ONCOLOGY

Amphiregulin and Epiregulin mRNA Expression in Primary Tumors Predicts Outcome in Metastatic Colorectal Cancer Treated With Cetuximab

(2009) Bart Jacobs et al.   JOURNAL OF CLINICAL ONCOLOGY

Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial

(2009) N. Mittmann et al.   JNCI-Journal of the National Cancer Institute

K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer

(2008) Christos S. Karapetis et al.   NEW ENGLAND JOURNAL OF MEDICINE